XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1

Note 16 - Dermadoctor Divestiture

3 Months Ended

Mar. 31, 2025

DERMAdoctor [Member]

Notes to Financial Statements

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

NOTE 16. DERMADOCTOR DIVESTITURE

On March 12, 2024, the Company entered into an agreement to sell 100% of the membership units of DERMAdoctor for a closing purchase price of $1.1 million (the “DERMAdoctor Divestiture”). The sale of the membership units closed, and the DERMAdoctor Divestiture occurred, on March 25, 2024. The accounting requirements for reporting the DERMAdoctor business as discontinued operations were met during the first quarter of 2024. Accordingly, the unaudited condensed consolidated financial statements and notes to the unaudited condensed consolidated financial statements reflect the results of the DERMAdoctor business as a discontinued operation for the years presented.

In accordance with the provisions of ASC 205-20, Presentation of Financial Statements: Discontinued Operations (“ASC 205-20”), the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of operations. The results of DERMAdoctor’s operations for the three months ended March 31, 2024 have been reflected as discontinued operations in the consolidated statements of operations and consist of the following (in thousands):

		For the three months ended March 31, 2024
Net sales		$	717
Cost of goods sold			493
Gross profit			224
Operating expenses
Research and development			2
Sales and marketing			292
General and administrative			48
Total operating expenses			342
Operating loss			(118	)
Loss on divestiture			(871	)
Net loss from discontinued operations		$	(989	)

In accordance with the provisions of ASC 205-20, the Company has not included in the results of continuing operations the results of operations of the discontinued operations in the consolidated statements of cash flows. The results of DERMAdoctor for the three months ended March 31, 2024 have been reflected as discontinued operations in the consolidated statements of cash flows and consist of the following (in thousands):

		For the three months ended March 31, 2024
Operating activities:
Net loss from discontinued operations		$	(989	)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash loss on divestiture			865
Changes in operating assets and liabilities:
Accounts receivable			(262	)
Inventory			183
Prepaid expenses and other current assets			(4	)
Other assets			15
Accounts payable and accrued liabilities			63
Operating lease liabilities			(31	)
Net cash used in operating activities, discontinued operations			(160	)
Investing activities:
Proceeds from divestiture			1,070
Cash transferred to New Age Investments, LLC			(46	)
Net cash provided by investing activities, discontinued operations			1,024
Net increase in cash and cash equivalents, discontinued operations		$	864

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/205-20/tableOfContent

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 360
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/360/tableOfContent

+ Details

Name:	us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=nby_DermadoctorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: